• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性药物成分在快速溶剂蒸发后的结晶倾向——分类及与过冷熔体结晶倾向的比较。

Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation--classification and comparison with crystallization tendency from undercooled melts.

机构信息

Department of Industrial and Physical Pharmacy, School of Pharmacy and Pharmaceutical Sciences, Purdue University, 575 Stadium Mall Drive, West Lafayette, Indiana 47907, USA.

出版信息

J Pharm Sci. 2010 Sep;99(9):3826-38. doi: 10.1002/jps.22214.

DOI:10.1002/jps.22214
PMID:20533435
Abstract

In this study, the crystallization behavior of a variety of compounds was studied following rapid solvent evaporation using spin coating. Initial screening to determine model compound suitability was performed using a structurally diverse set of 51 compounds in three different solvent systems [dichloromethane (DCM), a 1:1 (w/w) dichloromethane/ethanol mixture (MIX), and ethanol (EtOH)]. Of this starting set of 153 drug-solvent combinations, 93 (40 compounds) were selected for further evaluation based on solubility, chemical solution stability, and processability criteria. These systems were spin coated and their crystallization was monitored using polarized light microscopy (7 days, dry conditions). The crystallization behavior of the samples could be classified as rapid (Class I: 39 cases), intermediate (Class II: 23 cases), or slow (Class III: 31 cases). The solvent system employed influenced the classification outcome for only four of the compounds. The various compounds showed very diverse crystallization behavior. Upon comparison of classification results with those of a previous study, where cooling from the melt was used as a preparation technique, a good similarity was found whereby 68% of the cases were identically classified. Multivariate analysis was performed using a set of relevant physicochemical compound characteristics. It was found that a number of these parameters tended to differ between the different classes. These could be further interpreted in terms of the nature of the crystallization process. Additional multivariate analysis on the separate classes of compounds indicated some potential in predicting the crystallization tendency of a given compound.

摘要

在这项研究中,使用旋转涂层法通过快速溶剂蒸发研究了多种化合物的结晶行为。使用三种不同溶剂系统(二氯甲烷(DCM)、1:1(w/w)二氯甲烷/乙醇混合物(MIX)和乙醇(EtOH))中的 51 种具有不同结构的化合物进行了初始筛选,以确定模型化合物的适用性。在这个起始的 153 种药物-溶剂组合中,根据溶解度、化学溶液稳定性和可加工性标准,选择了 93 种(40 种化合物)进行进一步评估。这些系统被旋转涂层,并使用偏振光显微镜监测其结晶(7 天,干燥条件)。可以将样品的结晶行为分类为快速(I 类:39 种情况)、中间(II 类:23 种情况)或缓慢(III 类:31 种情况)。所使用的溶剂系统仅对四种化合物的分类结果产生影响。各种化合物表现出非常不同的结晶行为。将分类结果与先前使用熔融冷却作为制备技术的研究进行比较时,发现存在很好的相似性,其中 68%的情况被相同分类。使用一组相关的物理化学化合物特性进行了多元分析。发现这些参数中的许多参数在不同类别之间存在差异。可以根据结晶过程的性质进一步解释这些差异。对化合物的单独类别进行的额外多元分析表明,在预测给定化合物的结晶趋势方面具有一定的潜力。

相似文献

1
Crystallization tendency of active pharmaceutical ingredients following rapid solvent evaporation--classification and comparison with crystallization tendency from undercooled melts.活性药物成分在快速溶剂蒸发后的结晶倾向——分类及与过冷熔体结晶倾向的比较。
J Pharm Sci. 2010 Sep;99(9):3826-38. doi: 10.1002/jps.22214.
2
Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.小范围筛选以确定不同聚合物在快速溶剂蒸发时抑制药物结晶的能力。
Mol Pharm. 2010 Aug 2;7(4):1328-37. doi: 10.1021/mp1001153.
3
A classification system to assess the crystallization tendency of organic molecules from undercooled melts.一种评估有机分子从过冷熔体中结晶倾向的分类系统。
J Pharm Sci. 2010 Sep;99(9):3787-806. doi: 10.1002/jps.22197.
4
Drug loading into porous calcium carbonate microparticles by solvent evaporation.通过溶剂蒸发将药物载入多孔碳酸钙微粒中。
Eur J Pharm Biopharm. 2014 Aug;87(3):548-58. doi: 10.1016/j.ejpb.2014.02.009. Epub 2014 Feb 22.
5
Antisolvent membrane crystallization of pharmaceutical compounds.药物化合物的抗溶剂膜结晶。
J Pharm Sci. 2009 Dec;98(12):4902-13. doi: 10.1002/jps.21785.
6
Prediction of pharmaceutical solubility Via NRTL-SAC and COSMO-SAC.通过非随机双液体-统计缔合流体理论(NRTL-SAC)和导体屏蔽模型(COSMO-SAC)预测药物溶解度
J Pharm Sci. 2008 May;97(5):1813-20. doi: 10.1002/jps.21032.
7
Rational coformer or solvent selection for pharmaceutical cocrystallization or desolvation.理性共晶前体或溶剂选择用于药物共结晶或去溶剂化。
J Pharm Sci. 2012 Oct;101(10):3687-97. doi: 10.1002/jps.23227. Epub 2012 Jul 20.
8
Understanding the glass-forming ability of active pharmaceutical ingredients for designing supersaturating dosage forms.理解原料药的成玻璃能力,用于设计超饱和剂型。
J Pharm Sci. 2012 Sep;101(9):3239-48. doi: 10.1002/jps.23166. Epub 2012 Apr 24.
9
Classification of the crystallization behavior of amorphous active pharmaceutical ingredients in aqueous environments.水性环境中无定形活性药物成分结晶行为的分类
Pharm Res. 2014 Apr;31(4):969-82. doi: 10.1007/s11095-013-1216-z. Epub 2013 Nov 23.
10
Modeling the solubility of pharmaceuticals in pure solvents and solvent mixtures for drug process design.用于药物工艺设计的药物在纯溶剂和溶剂混合物中的溶解度建模。
J Pharm Sci. 2009 Nov;98(11):4205-15. doi: 10.1002/jps.21725.

引用本文的文献

1
Effects of hydrostatic compression and kinetic vitrification on structural relaxation behaviors of amorphous drugs: how to predict them simple theoretical models?静水压压缩和动态玻璃化对无定形药物结构松弛行为的影响:如何用简单理论模型预测它们?
RSC Adv. 2025 Jul 18;15(31):25675-25693. doi: 10.1039/d5ra03931b. eCollection 2025 Jul 15.
2
High-Throughput Microarray Approaches for Predicting the Stability of Drug-Polymer Solid Dispersions.用于预测药物-聚合物固体分散体稳定性的高通量微阵列方法
Mol Pharm. 2025 Jan 6;22(1):343-362. doi: 10.1021/acs.molpharmaceut.4c00955. Epub 2024 Dec 21.
3
The Amorphous Solid Dispersion of Chrysin in Plasdone S630 Demonstrates Improved Oral Bioavailability and Antihyperlipidemic Performance in Rats.
白杨素在聚维酮S630中的无定形固体分散体在大鼠中表现出改善的口服生物利用度和抗高血脂性能。
Pharmaceutics. 2023 Sep 24;15(10):2378. doi: 10.3390/pharmaceutics15102378.
4
Effect of Structurally Related Compounds on Desupersaturation Kinetics of Indomethacin.结构相关化合物对吲哚美辛去饱和动力学的影响。
Pharm Res. 2023 Dec;40(12):2769-2778. doi: 10.1007/s11095-023-03587-w. Epub 2023 Sep 5.
5
Analysis of Tolfenamic Acid using a Simple, Rapid, and Stability-indicating Validated HPLC Method.采用简单、快速、稳定指示的 HPLC 法分析托芬那酸。
Antiinflamm Antiallergy Agents Med Chem. 2024;23(1):52-70. doi: 10.2174/1871523022666230608094152.
6
Fed- and Fasted-State Performance of Pretomanid Amorphous Solid Dispersions Formulated with an Enteric Polymer.依托肠溶性聚合物的pretomanid 无定形固体分散体的进食和禁食状态性能。
Mol Pharm. 2023 Jun 5;20(6):3170-3186. doi: 10.1021/acs.molpharmaceut.3c00174. Epub 2023 May 23.
7
Supersaturation-Based Drug Delivery Systems: Strategy for Bioavailability Enhancement of Poorly Water-Soluble Drugs.基于过饱和的药物传递系统:提高难溶性药物生物利用度的策略。
Molecules. 2022 May 6;27(9):2969. doi: 10.3390/molecules27092969.
8
Combining enabling formulation strategies to generate supersaturated solutions of delamanid: In situ salt formation during amorphous solid dispersion fabrication for more robust release profiles.结合使能制剂策略以生成地拉米韦的过饱和溶液:在无定形固体分散体制备过程中进行原位成盐以实现更稳定的释放曲线。
Eur J Pharm Biopharm. 2022 May;174:131-143. doi: 10.1016/j.ejpb.2022.04.002. Epub 2022 Apr 9.
9
The Value of Bead Coating in the Manufacturing of Amorphous Solid Dispersions: A Comparative Evaluation with Spray Drying.珠粒包衣在无定形固体分散体制造中的价值:与喷雾干燥的比较评估
Pharmaceutics. 2022 Mar 11;14(3):613. doi: 10.3390/pharmaceutics14030613.
10
Exploring Taxifolin Polymorphs: Insights on Hydrate and Anhydrous Forms.探索紫杉叶素多晶型物:关于水合物和无水物形式的见解。
Pharmaceutics. 2021 Aug 25;13(9):1328. doi: 10.3390/pharmaceutics13091328.